Incyte Named a 2018 Top Employer by Science Magazine
Get Alerts INCY Hot Sheet
Join SI Premium – FREE
WILMINGTON, Del.--(BUSINESS WIRE)-- Incyte Corporation (Nasdaq: INCY) announced today that it has been named one of the global biotechnology and pharmaceutical industry’s top employers by Science magazine, ranking second on the list of only 20 companies recognized in the publicationâs annual Top Employerâs Survey.
âWe are proud to be recognized as the number two top employer in the biopharma industry by Science magazine and, importantly, also by our own team,â said Hervé Hoppenot, Chief Executive Officer, Incyte. âWe believe that the collective experience and passion of our over 1,300 talented colleagues is foundational to our success, and as our organization continues to grow, we are committed to maintaining a culture that is driven by a passion for innovative science and where patients are at the forefront of everything we do. Together, we strive to make a meaningful difference in the lives of patients with cancer and other serious diseases.â
The Science and Science Careersâ 2018 annual Top Employers Survey polled employees in biotechnology, pharmaceutical and related industries to determine the 20 best employers in these industries as well as their driving characteristics. Respondents were asked to evaluate companies based on 23 different characteristics, including financial strength, easy adaptation to change and a research-driven environment. Incyte was specifically recognized by its team members for its innovation, work culture and respect for employees.
According to Science, the 2018 rankings were based on a total sample of more than 8,000 respondents from North America (63 percent), Europe (24 percent) and Asia/Pacific Rim (9 percent).
The complete survey feature along with individual company rankings is available in the October 26, 2018, print issue of Science, and online: http://www.sciencemag.org/features/2018/10/top-employers-embrace-change-based-stable-foundation.
About Incyte
Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit the Companyâs website at www.incyte.com.
Follow @Incyte on Twitter at https://twitter.com/Incyte.
View source version on businesswire.com: https://www.businesswire.com/news/home/20181025005872/en/
Incyte Corporation
Catalina Loveman, +1 302-498-6171
[email protected]
Source: Incyte Corporation
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Incyte (INCY) PT Raised to $105 at Truist Securities
- Ovative Group Wins 2026 AMA Chicago Palmer Award for Engagement
- Development Manager Appointed
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share